Integral Health Asset Management, LLC Zai Lab LTD Transaction History

Integral Health Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	BUY	$23.14 - $49.68 $1.89 Million - $4.05 Million	81,554 Added 108.74%	156,554 $5.43 Million
Q1 2022 May 12, 2022	BUY	$27.77 - $64.4 $2.08 Million - $4.83 Million	75,000 New	75,000 $3.3 Million
Q3 2021 Nov 12, 2021	SELL	$105.0 - $178.37 $2.63 Million - $4.46 Million	-25,000 Closed	0 $0
Q2 2021 Aug 30, 2021	SELL	$125.11 - $180.0 $3.13 Million - $4.5 Million	-25,000 Reduced 50.0%	25,000 $4.43 Million
Q2 2021 Aug 13, 2021	BUY	$125.11 - $180.0 $625,550 - $900,000	5,000 Added 11.11%	50,000 $8.85 Million
Q1 2021 May 10, 2021	BUY	$126.27 - $191.71 $1.89 Million - $2.88 Million	15,000 Added 50.0%	45,000 $6 Million
Q4 2020 Feb 16, 2021	BUY	$81.94 - $135.34 $409,700 - $676,700	5,000 Added 20.0%	30,000 $4.06 Million
Q3 2020 Nov 16, 2020	BUY	$73.3 - $89.48 $1.83 Million - $2.24 Million	25,000 New	25,000 $2.08 Million

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.62B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.